Stapled-peptides have emerged as an exciting class of molecules which can modulate protein–protein interactions. We have used a structure-guided approach to rationally develop a set of hydrocarbon stapled-peptides with high binding affinities and residence times against the oncogenic eukaryotic translation initiation factor 4E (eIF4E) protein. Crystal structures of these peptides in complex with eIF4E show that they form specific interactions with a region on the protein-binding interface of eIF4E which is distinct from the other well-established canonical interactions. This recognition element is a major molecular determinant underlying the improved binding kinetics of these peptides with eIF4E. The interactions were further exploited by d...
The cover feature picture shows how inhibition of the histone H3‐ASF1 (anti‐silencing function 1) pr...
The exploitation of synthetic lethality by small-molecule targeting of pathways that maintain genomi...
The interaction between the eukaryotic translation initiation factor 4E (eIF4E) and eIF4E binding pr...
eIF4E is frequently over-expressed in different cancers and causes increased translation of oncogeni...
<div><p>Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breas...
Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head ...
Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head ...
With the increasing threat of multidrug resistant bacteria, there is a growing need to invent new dr...
Protein structure underlies essential biological processes and provides a blueprint for molecular mi...
Protein disorder plays a crucial role in signal transduction and is key for many cellular processes ...
Drug target studies elucidated the core role of protein-protein interaction (PPI) in human disease p...
Synthetic peptides that specifically bind nuclear hormone receptors offer an alternative approach to...
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a ma...
SummaryCap-dependent translation initiation is regulated by the interaction of eukaryotic initiation...
Drug target studies elucidated the core role of protein-protein interaction (PPI) in human disease p...
The cover feature picture shows how inhibition of the histone H3‐ASF1 (anti‐silencing function 1) pr...
The exploitation of synthetic lethality by small-molecule targeting of pathways that maintain genomi...
The interaction between the eukaryotic translation initiation factor 4E (eIF4E) and eIF4E binding pr...
eIF4E is frequently over-expressed in different cancers and causes increased translation of oncogeni...
<div><p>Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breas...
Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head ...
Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head ...
With the increasing threat of multidrug resistant bacteria, there is a growing need to invent new dr...
Protein structure underlies essential biological processes and provides a blueprint for molecular mi...
Protein disorder plays a crucial role in signal transduction and is key for many cellular processes ...
Drug target studies elucidated the core role of protein-protein interaction (PPI) in human disease p...
Synthetic peptides that specifically bind nuclear hormone receptors offer an alternative approach to...
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a ma...
SummaryCap-dependent translation initiation is regulated by the interaction of eukaryotic initiation...
Drug target studies elucidated the core role of protein-protein interaction (PPI) in human disease p...
The cover feature picture shows how inhibition of the histone H3‐ASF1 (anti‐silencing function 1) pr...
The exploitation of synthetic lethality by small-molecule targeting of pathways that maintain genomi...
The interaction between the eukaryotic translation initiation factor 4E (eIF4E) and eIF4E binding pr...